학술논문
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
Document Type
Article
Author
Langley, R.E.; Gilbert, D.C.; Duong, T.; Nankivell, M.; Macnair, A.; Deighan, J.V.; Marshall, J.; Forcat, S.; Weiss, M.; Parmar, M.; Clarke, N.W.; Rosen, S.D.; Mangar, S.; Sundaram, S.K.; Laniado, M.E.; Dixit, S.; Madaan, S.; Manetta, C.; Pope, A.; Scrase, C.D.; Mckay, S.; Alhasso, A.; Muazzam, I.A.; Collins, G.N.; Worlding, J.; Williams, S.T.; Paez, E.; Robinson, A.; McFarlane, J.; Kockelbergh, R.; Kynaston, H.
Source
In: The Lancet . (The Lancet, 13 February 2021, 397(10274):581-591)
Subject
Language
English
ISSN
1474547X
01406736
01406736